These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11980984)

  • 41. Medical treatment of a pacemaker endocarditis due to Candida albicans and to Candida glabrata.
    Roger PM; Boissy C; Gari-Toussaint M; Foucher R; Mondain V; Vandenbos F; le Fichoux Y; Michiels JF; Dellamonica P
    J Infect; 2000 Sep; 41(2):176-8. PubMed ID: 11023765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients.
    Lopez-Ribot JL; McAtee RK; Perea S; Kirkpatrick WR; Rinaldi MG; Patterson TF
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1621-30. PubMed ID: 10390213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy.
    Nicolatou-Galitis O; Velegraki A; Sotiropoulou-Lontou A; Dardoufas K; Kouloulias V; Kyprianou K; Kolitsi G; Skarleas C; Pissakas G; Papanicolaou VS; Kouvaris J
    Support Care Cancer; 2006 Jan; 14(1):44-51. PubMed ID: 15947956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice.
    Ju JY; Polhamus C; Marr KA; Holland SM; Bennett JE
    Antimicrob Agents Chemother; 2002 May; 46(5):1240-5. PubMed ID: 11959551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pediatric oropharyngeal candidiasis: A comprehensive study on risk factors and most prevalent species of Candida.
    Shirazi JH; Ali MI; Akhtar Z; Jamal A; Rashid A
    Pak J Pharm Sci; 2019 Nov; 32(6(Supplementary)):2873-2878. PubMed ID: 32024627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil.
    Pasqualotto AC; Zimerman RA; Alves SH; Aquino VR; Branco D; Wiltgen D; do Amaral A; Cechinel R; Colares SM; da Rocha IG; Severo LC; Sukiennik TC
    Infect Control Hosp Epidemiol; 2008 Sep; 29(9):898-9. PubMed ID: 18785850
    [No Abstract]   [Full Text] [Related]  

  • 47. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
    J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
    Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
    Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.
    Groll AH; Just-Nuebling G; Kurz M; Mueller C; Nowak-Goettl U; Schwabe D; Shah PM; Kornhuber B
    J Antimicrob Chemother; 1997 Dec; 40(6):855-62. PubMed ID: 9462438
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluconazole prophylaxis in patients with head and neck tumours undergoing radiation and radiochemotherapy.
    Mücke R; Kaben U; Libera T; Knauerhase H; Ziegler PG; Hamann D; Strietzel M
    Mycoses; 1998 Nov; 41(9-10):421-3. PubMed ID: 9916467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival in Patients with Candida glabrata Bloodstream Infection Is Associated with Fluconazole Dose.
    Eschenauer GA; Carver PL; Patel TS; Lin SW; Klinker KP; Pai MP; Lam SW
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581112
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology and prevalence of oropharyngeal candidiasis in Spanish patients with head and neck tumors undergoing radiotherapy treatment alone or in combination with chemotherapy.
    Mañas A; Cerezo L; de la Torre A; García M; Alburquerque H; Ludeña B; Ruiz A; Pérez A; Escribano A; Manso A; Glaria LA;
    Clin Transl Oncol; 2012 Oct; 14(10):740-6. PubMed ID: 22960994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
    Khan F; Baqai R
    J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients.
    Quereda C; Polanco AM; Giner C; Sánchez-Sousa A; Pereira E; Navas E; Fortún J; Guerrero A; Baquero F
    Eur J Clin Microbiol Infect Dis; 1996 Jan; 15(1):30-7. PubMed ID: 8641300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes associated with routine systemic antifungal therapy in critically ill patients with Candida colonization.
    Ferreira D; Grenouillet F; Blasco G; Samain E; Hénon T; Dussaucy A; Millon L; Mercier M; Pili-Floury S
    Intensive Care Med; 2015 Jun; 41(6):1077-88. PubMed ID: 25894623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
    BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of oropharyngeal mycosis in head and neck cancer occurring during (chemo) radiotherapy: an Italian radio-oncologist survey.
    Belgioia L; Bacigalupo A; Alterio D; Russi E; Corvò R
    Tumori; 2015; 101(3):312-7. PubMed ID: 25908051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-dose fluconazole therapy for cancer patients with solid tumors and candidemia: an observational, noncomparative retrospective study.
    Torres HA; Kontoyiannis DP; Rolston KV
    Support Care Cancer; 2004 Jul; 12(7):511-6. PubMed ID: 14986077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
    Petraitis V; Petraitiene R; Groll AH; Sein T; Schaufele RL; Lyman CA; Francesconi A; Bacher J; Piscitelli SC; Walsh TJ
    Antimicrob Agents Chemother; 2001 Feb; 45(2):471-9. PubMed ID: 11158743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.